Skip to main content
Log in

Undetectable thyrotropin levels using immunoradiometric assay in l-dopa-treated patients

  • Letters To The Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Caldwell G, Kellet HA, Gow SM, Beckett GJ, Sweeting VM, Seth J, Toft AD (1985) A new strategy for thyroid function test. Lancet I:1117–1119

    Google Scholar 

  2. Finlayson J, Sneddon W, Percy-Rose IW (1987) Interference in commercial assays for thyrotropin. Lancet I:445–446

    Google Scholar 

  3. John R, Henley R (1987) Interference in commercial assays for thyrotropin. Lancet I:446

    Google Scholar 

  4. Kirkegaard C, Bregeng»rd C, Feldt-Rasmussen U, Bech K, Faber J (1985) Thyroid test strategy. Lancet I:1455

    Google Scholar 

  5. Møller A, Perrild H, Høyer-Madsen M, Langvad Hansen B, Pedersen H (1987) Parkinson's disease and autoimmunity. Acta Neurol (in press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perrild, H., Møller, A., Pedersen, H. et al. Undetectable thyrotropin levels using immunoradiometric assay in l-dopa-treated patients. J Neurol 235, 255 (1988). https://doi.org/10.1007/BF00314361

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314361

Keywords

Navigation